Polycystic Ovary syndrome: A Randomised feasibility and pilot study using Chinese Herbal medicine to explore Impact on Dysfunction (ORCHID)-Study protocol

European Journal of Integrative Medicine

Volumn 6, Issue 3, 2014, Pages 392-399

  Lai, Lily ^a   Flower, Andrew ^a   Moore, Michael ^a   Prescott, Philip ^a   Lewith, George ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Chinese herbal medicine; Feasibility study; Menstrual disorders; Pilot; Polycystic ovary syndrome; Randomised controlled trial

Indexed keywords

HERBACEOUS AGENT; ANGELICA SINENSIS EXTRACT; BUPLEURUM ROOT EXTRACT; CINNAMOMUM CASSIA EXTRACT; CITRUS RETICULATATA EXTRACT; CUSCUTA CHINENSIS EXTRACT; CYPERUS ROTUNDUS EXTRACT; GLYCYRRHIZA EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; LEONURUS JAPONICUS EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; LYCIUM BARBARUM EXTRACT; PAEONIA LACTIFLORA EXTRACT; PLANT EXTRACT; PRESCRIPTION DRUG; PRUNUS PERSICA EXTRACT; SAFFLOWER EXTRACT; SOUR ORANGE EXTRACT; UNCLASSIFIED DRUG;

AMENORRHEA; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE MEDICINE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DERMATOLOGY LIFE QUALITY INDEX; DRUG SAFETY; FEASIBILITY STUDY; HERBAL MEDICINE; HUMAN; KIDNEY FUNCTION; LIVER FUNCTION; MEASURE YOURSELF MEDICAL OUTCOME PROFILE; MENSTRUAL CYCLE; MODIFIED FERRIMAN GALLWEY SCALE; MORISKY MEDICATION ADHERENCE SCALE; MULTICENTER STUDY; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PHYSICIAN; PILOT STUDY; POLYCYSTIC OVARY SYNDROME QUESTIONNAIRE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; WAIST HIP RATIO; ADULT; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GENITAL SYSTEM DISEASE ASSESSMENT; HEALTH IMPACT ASSESSMENT; INTERVENTION STUDY; OLIGOMENORRHEA; PARALLEL DESIGN; PATIENT COMPLIANCE; PERSONALIZED MEDICINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT RESPONSE;

EID: 84901825890     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2014.03.001     Document Type: Article

References (36)

1. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000, 85(7):2434-2438.
2. March W.A., Moore V.M., Willson K.J., Phillips D.I., Norman R.J., Davies M.J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010, 25(2):544-551.
3. Ehrmann D.A. Polycystic ovary syndrome. N Engl J Med 2005, 352(12):1223-1236.
4. Sills E.S., Perloe M., Tucker M.J., Kaplan C.R., Genton M.G., Schattman G.L. Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports. BMC Womens Health 2001, 1(1):3.
5. Fleming R., Hopkinson Z.E., Wallace A.M., Greer I.A., Sattar N. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002, 87(2):569-574.
6. Donnan P.T., MacDonald T.M., Morris A.D. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 2002, 19(4):279-284.
7. Grant R.W., Devita N.G., Singer D.E., Meigs J.B. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care 2003, 26(5):1408-1412.
8. Legro R.S., Barnhart H.X., Schlaff W.D., Carr B.R., Diamond M.P., Carson S.A., et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356(6):551-566.
9. Raja-Khan N., Stener-Victorin E., Wu X., Legro R.S. The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab 2011, 301(1):E1-E10.
10. MRC A framework for development and evaluation of RCTs for complex interventions to improve health 2000, Medical Research Council.
11. Lancaster G.A., Dodd S., Williamson P.R. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004, 10(2):307-312.
12. Craig P., Dieppe P., Macintyre S., Michie S., Nazareth I., Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008, 337:a1655.
13. Arain M., Campbell M.J., Cooper C.L., Lancaster G.A. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 2010, 10:67.
14. Thabane L., Ma J., Chu R., Cheng J., Ismaila A., Rios L.P., et al. A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol 2010, 10:1.
15. Maciocia M. The foundations of Chinese medicine: a comprehensive text for acupuncturists and herbalists 1997, Elsevier Churchill Livingstone, Edinburgh.
16. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004, 81(1):19-25. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
17. Ward E., Bower P., Collier D., Delaney B., Graffy J., Kinmonth A.-L., et al. Primary care research recruitment: a practical guide 2010, National Institute for Health Research.
18. Jedel E., Labrie F., Oden A., Holm G., Nilsson L., Janson P.O., et al. Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2011, 300(1):E37-E45.
19. Bell-Syer S.E., Thorpe L.N., Thomas K., Macpherson H. GP participation and recruitment of patients to RCTs: lessons from trials of acupuncture and exercise for low back pain in primary care. Evid Based Complement Alternat Med 2011, 2011:687349.
20. Johansson J., Redman L., Veldhuis P.P., Sazonova A., Labrie F., Holm G., et al. Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2013, 304(9):E934-E943.
21. Flower A., Lewith G.T., Little P. A feasibility study exploring the role of Chinese herbal medicine in the treatment of endometriosis. J Altern Complement Med 2011, 17(8):691-699.
22. Yasmin E., Glanville J., Barth J., Balen A.H. Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2011, 156(1):67-71.
23. Gagnier J., Boon H., Rochon P., Barnes J., Moher D., Bombardier C. Improving the quality of reporting of randomized controlled trials evaluating herbal interventions: implementing the CONSORT statement [corrected]. Explore (NY) 2006, 2(2):143-149.
24. NICE Obesity: guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children 2006, National Institute for Health and Clinical Excellence, London, UK.
25. Moran L.J., Lombard C.B., Lim S., Noakes M., Teede H.J. Polycystic ovary syndrome and weight management. Womens Health (Lond Engl) 2010, 6(2):271-283.
26. WHO Waist circumference and waist-hip ratio: report of a WHO expert consultation 2008.
27. Cronin L., Guyatt G., Griffith L., Wong E., Azziz R., Futterweit W., et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998, 83(6):1976-1987.
28. Paterson C. Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. BMJ 1996, 312(7037):1016-1020.
29. Guyatt G.H., Juniper E.F., Walter S.D., Griffith L.E., Goldstein R.S. Interpreting treatment effects in randomised trials. BMJ 1998, 316(7132):690-693.
30. Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19(3):210-216.
31. Basra M.K., Fenech R., Gatt R.M., Salek M.S., Finlay A.Y. The dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008, 159(5):997-1035.
32. Yildiz B.O., Bolour S., Woods K., Moore A., Azziz R. Visually scoring hirsutism. Hum Reprod Update 2010, 16(1):51-64.
33. Thue G., Sandberg S. Performance of the Reflotron and the Seralyzer in primary health care. Scand J Clin Lab Invest 1993, 53(3):253-261.
34. Kolahi J., Bang H., Park J. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol 2009, 37(6):477-484.
35. Morisky D.E., Green L.W., Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986, 24(1):67-74.
36. Devilly G.J., Borkovec T.D. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 2000, 31(2):73-86.